Inhibition of the Epstein–Barr virus lytic cycle by Zta-targeted RNA interference
- 1 June 2004
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 85 (6) , 1371-1379
Abstract
Epstein–Barr virus (EBV) reactivation into the lytic cycle plays certain roles in the development of EBV-associated diseases, so an effective strategy to block the viral lytic cycle may be of value to reduce the disease risk or to improve the clinical outcome. This study examined whether the EBV lytic cycle could be inhibited using RNA interference (RNAi) directed against the essential viral gene Zta. In cases of EBV reactivation triggered by chemicals or by exogenous Rta, Zta-targeted RNAi prevented the induction of Zta and its downstream genes and further blocked the lytic replication of viral genomes. This antiviral effect of RNAi was not likely to be mediated by activation of the interferon pathway, as phosphorylation of STAT1 was not induced. In addition, novel EBV-infected epithelial cells showing constitutive activation of the lytic cycle were cloned; such established lytic infection was also suppressed by Zta-targeted RNAi. These results indicate that RNAi can be used to inhibit the EBV lytic cycle effectively in vitro and could also be of potential use to develop anti-EBV treatments.Keywords
This publication has 47 references indexed in Scilit:
- Killing the messenger: short RNAs that silence gene expressionNature Reviews Molecular Cell Biology, 2003
- RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcriptionProceedings of the National Academy of Sciences, 2003
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Chromosomal integration of Epstein ‐ Barr virus genomes in nasopharyngeal carcinoma cellsHead & Neck, 2002
- Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese MenNew England Journal of Medicine, 2001
- The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivatorsThe EMBO Journal, 2000
- Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal KinasesJournal of Virology, 2000
- Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma riskCarcinogenesis, 1995
- Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.Proceedings of the National Academy of Sciences, 1991
- Final case reporting from the ugandan prospective study of the relationship between ebv and burktit's lymphomaInternational Journal of Cancer, 1982